These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 200004)

  • 1. [Adenosine-3',5'-monophosphate phosphodiesterase of the cerebral cortex and the effect of cardiovascular preparations].
    Libinzon RE; Shchekoldina TG; Batolkina OE; Iagniatinskaia AM
    Vopr Med Khim; 1977; 23(4):526-30. PubMed ID: 200004
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic 3',5'-adenosine monophosphate phosphodiesterase (cAMP PDE) and cyclic 3',5'-guanosine monophosphate phosphodiesterase (cGMP PDE) in microvessels isolated from bovine cortex.
    Stefanovich V
    Neurochem Res; 1979 Dec; 4(6):681-7. PubMed ID: 232543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
    Du Moulin A; Schultz J
    Experientia; 1975 Aug; 31(8):883-4. PubMed ID: 169139
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH; Brenner MJ; Muschek LD
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M; Harris DN
    Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5'-nucleotidase.
    Heyliger CE; Panagia V; Dhalla NS
    J Pharmacol Exp Ther; 1981 May; 217(2):489-93. PubMed ID: 6262487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New aspects in the mechanism of action of cardiac glycosides].
    Böhm A
    Cesk Pediatr; 1973 Jan; 28(1):35-8. PubMed ID: 4734380
    [No Abstract]   [Full Text] [Related]  

  • 8. The interaction of 4-alkyl derivatives of 2,6,7-trioxa-1-phosphabicyclo [2,2,2] octanes with cyclic adenosine 3',5'-monophosphate phosphodiesterase, and with cyclic adenosine 3',5'-monophosphate binding proteins.
    Coult DB; Wilkinson RG
    Biochem Pharmacol; 1977 May; 26(9):887-9. PubMed ID: 193519
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of beef cortex membrane-bound 3', 5'-AMP phosphodiesterase by halogenated purines.
    Macdonald IA
    Pharmacol Res Commun; 1977 Jan; 9(1):49-58. PubMed ID: 194263
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of digoxin, strophanthin and isolanid on oxygen absorption, oxidative phosphorylation and the amount of cytochromes in the myocardial mitochondria and their ATPase activity].
    Tsyganiĭ AA; Medvinskaia NA; Rudenko AF
    Farmakol Toksikol; 1982; 45(1):30-2. PubMed ID: 6459955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.
    Nagata K; Ogawa T; Omosu M; Fujimoto K; Hayashi S
    Arzneimittelforschung; 1985; 35(7):1034-6. PubMed ID: 2996562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylxanthine effects on cyclic adenosine 3':5' monophosphate phosphodiesterase activity in preparations of neonatal rat cerebellum: modification by trifluoperazine.
    Dunlop M; Larkins RG; Court JM
    Biochem Biophys Res Commun; 1981 Feb; 98(3):850-7. PubMed ID: 6164367
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of methylxanthines on catecholamine and adenylate nucleotide concentration in rat myocardium].
    Frantsuzova SB
    Biull Eksp Biol Med; 1974 Oct; 78(10):61-4. PubMed ID: 4461123
    [No Abstract]   [Full Text] [Related]  

  • 14. [The iduretic effect of cardiac glycosides].
    Sycheva IM
    Kardiologiia; 1971; 11(4):148-55. PubMed ID: 4938139
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of 5'-nucleotidase in rat brain by methylxanthines.
    Tsuzuki J; Newburgh RW
    J Neurochem; 1975 Dec; 25(6):895-6. PubMed ID: 173803
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic AMP phosphodiesterase activity in fetal and adult muscle of the rhesus monkey.
    Bocek RM; Beatty CH
    Dev Biol; 1976 Feb; 48(2):382-91. PubMed ID: 176071
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of quasi-morphine withdrawal behaviour induced by methylxanthines.
    Butt NM; Collier HO; Cuthbert NJ; Francis DL; Saeed SA
    Eur J Pharmacol; 1979 Feb; 53(4):375-8. PubMed ID: 217699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardioactive agents. 49].
    Kretschmer P; Selchau M
    Pharm Prax; 1970; 12():266-85. PubMed ID: 5532356
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular and renal actions of methylxanthines.
    Fredholm BB
    Prog Clin Biol Res; 1984; 158():303-30. PubMed ID: 6098900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW; Daly JW
    Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.